Dr. Philip McCarthy from the Roswell Park Cancer Institute, talks about the multiple myeloma clinical trials and abstracts presented at the annual American Society of Clinical Oncologists (ASCO) meeting in Chicago, IL.


Dr. Philip McCarthy is a Professor of Oncology and Internal Medicine and the Director of the Transplant and Cellular Therapy Center at the Roswell Comprehensive Cancer Center in Roswell Park, New York. He also holds the position of Professor of Oncology and Internal Medicine at the Chief of Plasma Cell Disorders and Director of Clinical Research in Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo in Buffalo, New York. View Dr. Philip MCarthy’s full biography here.

Previous Post
ASCO 2017: Multiple Myeloma Overview -- Dr. Saad Usmani
Next Post
ASCO 2017: Multiple Myeloma Highlights -- Dr. Joseph Mikhael

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.